The public tranche will close on Feb 14, 12pm, while shares in SAM Holdings will be traded on the Catalist board of SGX on Feb 16.
Singapore Institute of Advanced Medicine Holdings (SAM Holdings), which aims to become a comprehensive one-stop ambulatory cancer centre, has successfully completed the registration of its offer document in connection with its proposed initial public offering (IPO) and listing on the Catalist Board SGX and is now open for subscription by the public.
The public tranche will see some 4.415 million shares offered at 23 cents per share. Together with 109.585 million placement shares also at 23 cents per share, the group has offered 114 million invitation shares.
